« Spoligotyping » (tubercle bacilli Direct Repeat or CRISPR genotyping) has more than 750 bibliographical references on PubMed between 1997 and 2013. Invented in 1997 at the RIVM in the Nederlands, the original technique on membrane (reverse line-blot hybridization), was transfered on a microbeads format in the CDC in 2004. The IGM is in Europe among the experts in CRISPR loci typing on microbeads and a partner of Luminex®.
We propose both custom genotyping services as well as are selling oligonucleotide-coupled microbeads, whether polystyrene ou paramagnetic, to run CRISPR typing techniques to prevent infectious diseases spreading on Luminex devices. We also supply training to data-analysis and interpretation sofwares. Contact us for a quote or any specific request. Our dedicated team will be happy to answer you.
for Research Use Only
Université Paris Sud
+33 1 69 15 46 46 or 46 48
SIRET 809 330 806 00013, Code: APE 7211Z
VAT n°: FR77809330806.
Director of Publication : Christophe Sola
Website Administration :
Pasquale Cutolo, Clement Ripoll
Coming soon : general review on the ESM congress (held in Sibenik from June 25th till June 28th 2017)
Why should you switch from membrane to microbead-based spoligotyping ?
A new Allele call Macro for TB-RINT users is available